Global Health Innovation and the Paradox of Choice in Healthcare (Hassan Chaudhury)

04/14/22 • 47 min

1 Listener

Hassan Chaudhury is a global healthcare expert, he worked in several countries across the world. He currently works at Healthcare UK; a joint initiative of the Department of Health and Social Care, NHS England and the Department for International Trade (DIT). His global role includes advising commercial teams in over 100 UK embassies. In this discussion, we chatted about the digital transformation of healthcare and social care in the UK and Hassan’s experience with countries across the world. Which innovations are reasonable to implement in healthcare today? And which technologies are currently not ready for prime time just yet. You might be surprised by Hassan’s opinion.

Read an excerpt:

Read an excerpt:

Previous Episode

What Can Digital Health Innovators Learn from Oncology? (Sean Khozin)

Therapies for cancer are being developed at light speed and upward of 60 gene and cell therapies are projected to reach regulatory approval in the U.S. by 2030, according to the MIT NEWDIGS collaborative. Due to the nature of cancer, readiness for risks in drug development is much higher here than it might be in other medical fields. In this episode you’re going to hear a bit more about what can digital health innovation learn from the mindset present in oncology development.

Sean Khozin is the CEO of CancerLinQ, a non-profit health technology company focused on improving quality of care and health outcomes for all patients with cancer. He was the Global Head of Data Strategy and Data Science Innovation at Johnson & Johnson, before that he co-founded Hello Health, a technology company focused on developing integrated telemedicine, point-of-care data visualization, and advanced analytical systems for optimizing patient care and clinical research. He was also the Founding director of a digital health incubator inside the FDA.

You will hear a little bit about processes in oncology, innovation in oncology, the promise of decentralized clinical trials and more.

Leave a rating or review: lovethepodcast.com/facesofdigitalhealth

Next Episode

Startup Health: "We Need To Think About Healthcare Globally, Not Locally" (Unity Stoakes)

Investments in digital health have been steadily rising for the last seven years. 6.2 billion dollars were invested in digital health startups in 2015, 44 billion in 2022, according to Startup Health. Startup Health is a US-based organisation supporting digital health innovators across the world and globally spreading optimism about the potential of technology in healthcare. The vision that drives that optimism is the hope that we can bring access to healthcare to everyone in the world, that we can beat cancer and cure diseases such as diabetes or Alzheimer’s. That vision is important because healthcare innovation is not for the faint-hearted and as health indicators show, currently, life expectancy and health are worsening across the world, says co-founder and president of Startup Health Unity Stoakes. The market is maturing, he says, which is also seen in the number of companies that attract investments. The total amount of investments has been increasing for several years, but th number of companies that are invested in, is staying roughly the same - it’s just that some companies are maturing and raising higher amounts of funding. In this discussion you will hear Unity Stoakes talk about his reflection of Startup Health which is already 11 years old, he talked about the global expansion of Startup Health, why we need to think about healthcare innovation less locally, more globally, and also why we still need much more investments in the future.

If you want to go down the memory lane of digital health, you can also tune in to the interview with Unity in 2017: https://podcasts.apple.com/si/podcast/faces-of-digital-health/id1194284040?i=1000380325225